TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/14/23 19:16 | 2/10/23 | PRVB | Provention Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hoitt Jason | NJ | O | Chief Co | S | -45 | 10.00 | 0 | -5 | -100 | 0 | D | ||||||||||||||
3/20/20 06:15 | 3/19/20 | PRVB | Provention Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hoitt Jason | NJ | O | Chief Co | P | 24 | 5.43 | 0 | 5 | New | 5 | D | ||||||||||||||
10/2/19 16:20 | 9/30/19 | DOVA | Dova Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hoitt Jason | NC | O | Chief Co | S | -67 | 28.00 | 0 | -2 | -19 | 10 | D | ||||||||||||||
7/16/19 16:29 | 7/15/19 | DOVA | Dova Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hoitt Jason | NC | O | Chief Co | S | -116 | 15.26 | 0 | -8 | -38 | 12 | D | ||||||||||||||
7/2/19 16:55 | 6/28/19 | DOVA | Dova Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hoitt Jason | NC | O | Chief Co | S | -33 | 13.81 | 0 | -2 | -11 | 20 | D | ||||||||||||||
4/10/19 16:48 | 4/8/19 | DOVA | Dova Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hoitt Jason | NC | O | Chief Co | S | -21 | 8.77 | 0 | -2 | -10 | 22 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |